Physician profile
Daniel K Mcbride
NPI 1770699894
$2,485.90
in general payments reported to CMS, 2019-2025
18 companies · $1,694 in 2025
The $1,694 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $76.41 · 2021: $46.77 · 2022: $38.36 · 2023: $151 · 2024: $312 · 2025: $1,694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,226 · Travel and Lodging: $931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.11 |
| Travel and Lodging | $931.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,197.85 | 2025 | Aveir |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $276.83 | 2019-2025 | Xifaxan |
| Medtronic, INC. | $174.55 | 2025 | Micra |
| Boston Scientific Corporation | $125.96 | 2025 | General - Therapies, Emblem Mri S-Icd |
| Merck Sharp & Dohme LLC | $121.68 | 2020-2025 | Bridion |
| Heron Therapeutics, INC. | $112.68 | 2023-2024 | Aponvie, Zynrelef |
| Regeneron Healthcare Solutions, INC. | $94.90 | 2022-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $78.72 | 2019-2024 | Gattex, Entyvio |
| Abbvie INC. | $69.53 | 2019-2024 | |
| Intercept Pharmaceuticals, INC. | $49.70 | 2019-2024 | Ocaliva |
| Madrigal Pharmaceuticals | $49.69 | 2025 | Rezdiffra |
| Shionogi INC | $33.03 | 2019 | |
| Glaxosmithkline, LLC. | $22.25 | 2025 | Shingrix |
| Pacira Pharmaceuticals Incorporated | $17.92 | 2021 | |
| Ucb, INC. | $17.17 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $16.57 | 2024 | Simponi Aria, Simponi, Stelara |
| Alcon Vision LLC | $14.35 | 2019 | |
| Braintree Laboratories, INC. | $12.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.